ATE126054T1 - Entzündungshemmende arzneimittel zur äusserlichen anwendung. - Google Patents
Entzündungshemmende arzneimittel zur äusserlichen anwendung.Info
- Publication number
- ATE126054T1 ATE126054T1 AT90312313T AT90312313T ATE126054T1 AT E126054 T1 ATE126054 T1 AT E126054T1 AT 90312313 T AT90312313 T AT 90312313T AT 90312313 T AT90312313 T AT 90312313T AT E126054 T1 ATE126054 T1 AT E126054T1
- Authority
- AT
- Austria
- Prior art keywords
- external use
- inflammatory drugs
- alkyl
- ability
- preparation
- Prior art date
Links
- 229940124599 anti-inflammatory drug Drugs 0.000 title 1
- -1 alkene esters Chemical class 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 230000003110 anti-inflammatory effect Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 235000014113 dietary fatty acids Nutrition 0.000 abstract 1
- 229930195729 fatty acid Natural products 0.000 abstract 1
- 239000000194 fatty acid Substances 0.000 abstract 1
- 150000004665 fatty acids Chemical class 0.000 abstract 1
- 230000035699 permeability Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003431 steroids Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AR31543389 | 1989-11-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE126054T1 true ATE126054T1 (de) | 1995-08-15 |
Family
ID=3478737
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT90312313T ATE126054T1 (de) | 1989-11-14 | 1990-11-12 | Entzündungshemmende arzneimittel zur äusserlichen anwendung. |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP0428352B1 (de) |
| JP (1) | JPH03275621A (de) |
| AT (1) | ATE126054T1 (de) |
| BR (1) | BR9005878A (de) |
| DE (1) | DE69021511T2 (de) |
| DK (1) | DK0428352T3 (de) |
| ES (1) | ES2083437T3 (de) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3190441B2 (ja) * | 1992-07-20 | 2001-07-23 | エーザイ株式会社 | 塩酸アゼラスチンを含有する安定な製剤 |
| HU209518B (en) * | 1992-12-23 | 1994-06-28 | Egyt Gyogyszervegyeszeti Gyar | Process for production of free of skin damaging effect unguent preparation containing piroxicam |
| JP4181232B2 (ja) | 1997-07-18 | 2008-11-12 | 帝國製薬株式会社 | ジクロフェナクナトリウム含有油性外用貼付製剤 |
| KR19990026792A (ko) | 1997-09-26 | 1999-04-15 | 김윤 | 디클로페낙 디에틸암모늄염을 함유한 매트릭스형 패취제제 |
| KR100288190B1 (ko) * | 1998-02-09 | 2001-04-16 | 김용규 | 피록시캄 함유 알콜성 하이드로겔 조성물 |
| CA2330435A1 (en) * | 1998-04-28 | 1999-11-04 | Aggelos Nikolopoulos | Process for the preparation of aceclofenac |
| JP2000143540A (ja) * | 1998-11-06 | 2000-05-23 | Bristol Myers Squibb Co | 非ステロイド系消炎鎮痛薬含有外用剤 |
| DE102007034976A1 (de) | 2007-07-26 | 2009-01-29 | Bayer Healthcare Ag | Arzneimittel zur transdermalen Anwendung bei Tieren |
| US11452701B2 (en) | 2017-12-04 | 2022-09-27 | Johnson & Johnson Consumer Inc. | Topical emulsion composition containing nonsteroidal anti-inflammatory drug |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4837025A (en) * | 1988-03-25 | 1989-06-06 | Laboratoires D'hygiene Et De Dietetique | Self-adhesive device for the percutaneous administration of an active ingredient |
-
1990
- 1990-11-12 DK DK90312313.1T patent/DK0428352T3/da active
- 1990-11-12 AT AT90312313T patent/ATE126054T1/de not_active IP Right Cessation
- 1990-11-12 DE DE69021511T patent/DE69021511T2/de not_active Expired - Fee Related
- 1990-11-12 EP EP90312313A patent/EP0428352B1/de not_active Expired - Lifetime
- 1990-11-12 ES ES90312313T patent/ES2083437T3/es not_active Expired - Lifetime
- 1990-11-14 BR BR909005878A patent/BR9005878A/pt not_active Application Discontinuation
- 1990-11-14 JP JP2308424A patent/JPH03275621A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP0428352A1 (de) | 1991-05-22 |
| DE69021511T2 (de) | 1996-11-21 |
| ES2083437T3 (es) | 1996-04-16 |
| EP0428352B1 (de) | 1995-08-09 |
| JPH03275621A (ja) | 1991-12-06 |
| DE69021511D1 (de) | 1995-09-14 |
| DK0428352T3 (da) | 1995-12-27 |
| BR9005878A (pt) | 1991-09-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE53301T1 (de) | Systeme zur verbesserung der durchdringungsfaehigkeit und deren zubereitung. | |
| BR1100860A (pt) | Composto, droga antiinflamatória, composição farmacêutica, epìmero r e epìmero s do composto | |
| FI893520A0 (fi) | Menetelmä intravenoosisen farmaseuttisen koostumuksen valmistamiseksi | |
| IL122208A0 (en) | Sidechain-bearing taxanes methods for the preparation thereof and pharmaceutical compositions containing them | |
| MX9203026A (es) | Enantiomero dextrogiro del alfa-(tetrahidro-4,5,5-tieno (3,2-c) piridil-5) (cloro-2 fenil)-acetato de metilo y composiciones farmaceuticas que lo contienen. | |
| HUT46654A (en) | Process for producing substituted basic 2-amino-tetralin derivatives and pharmaceutical compositions comprising the same as active ingredient | |
| DE3786316D1 (de) | Ueberzugsmembran und damit hergestellte mittel. | |
| AU1578688A (en) | Pharmaceutical composition, for oral administration, designed to attenuate the effects of beta-lactamines | |
| FI931031A0 (fi) | Mometasonfuroatmonohydrat, foerfarande foer dess framstaellning och farmaceutiska sammansaettningar | |
| DE69033538D1 (de) | Verfahren zur Herstellung der 1,2-Doppelbindung von 4-aza-Steroiden und kristallinen Proscor(R) und pharmazeutische Präparate davon | |
| PT86018A (en) | Process for the preparation of alpha-amino-alpha-(alkylphenyl)-alkyl-ethanoic acids and their by-products and pharmaceutical compositions therewith | |
| AU2951489A (en) | Improving the stability of pharmaceutical compositions | |
| ATE126054T1 (de) | Entzündungshemmende arzneimittel zur äusserlichen anwendung. | |
| DK0400522T3 (da) | Fremgangsmåde til fremstilling af mikroniserede bionedbrydelige partikler | |
| AU6461090A (en) | Injectable formulation for lipophilic drugs | |
| DK99987A (da) | Oestrogenpraeparater | |
| CA2136071A1 (en) | 2-arylpropionic acid compositions and process for preparing the same | |
| NO873514D0 (no) | Fremgangsmaate for fremstilling av farmasoeytisk aktive forbindelser. | |
| NO891574D0 (no) | Fremgangsmaate for fremstilling av farmasoeytisk anvendbareforbindelser. | |
| PT87031A (pt) | Process for the preparation of 4-phenylpiperidine compounds an d of pharmaceutical compositions therewith | |
| DE2965364D1 (en) | Alpha-difluoromethyl amino acids and pharmaceutical composition containing the same | |
| NO903291D0 (no) | Renin-hemmende aminooligohydroksy-derivater. | |
| DE68914175D1 (de) | Parfümgrundzusammenstellung enthaltendes 2-cyclohexylpropanal und Verfahren zur Herstellung dieser Verbindung. | |
| ES2062313T3 (es) | 13-bromo- y 13,14-dibromo-ergolinas, a su preparacion y a su utilizacion en medicamentos. | |
| PT84950B (pt) | Process for the preparation of alkoxyalkyl and alkylmercaptoalkyl substituted bridged benzofuroisoquinolines and of pharmaceutical compositions containing the same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |